Global Fc Fusion Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fc Fusion Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
This report will focus on Fc fusion protein drugs.
Fc Fusion Protein report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fc Fusion Protein market is projected to reach US$ 60530 million in 2034, increasing from US$ 29470 million in 2022, with the CAGR of 10.7% during the period of 2024 to 2034. Demand from Autoimmune Disease and Eye Diseases are the major drivers for the industry.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fc Fusion Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fc Fusion Protein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fc Fusion Protein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fc Fusion Protein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fc Fusion Protein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fc Fusion Protein introduction, etc. Fc Fusion Protein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fc Fusion Protein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
This report will focus on Fc fusion protein drugs.
Fc Fusion Protein report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fc Fusion Protein market is projected to reach US$ 60530 million in 2034, increasing from US$ 29470 million in 2022, with the CAGR of 10.7% during the period of 2024 to 2034. Demand from Autoimmune Disease and Eye Diseases are the major drivers for the industry.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fc Fusion Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fc Fusion Protein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fc Fusion Protein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fc Fusion Protein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fc Fusion Protein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fc Fusion Protein introduction, etc. Fc Fusion Protein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fc Fusion Protein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.